Radiopharmaceutical diagnostic agent: Class Overview and Comparison
Quick answer: Radiopharmaceutical diagnostic agent are a class of medicines used for specific therapeutic indications. iMedic covers 7 radiopharmaceutical diagnostic agent substances. Below is a comparison table linking to detailed pages for each.
Radiopharmaceutical diagnostic agent on iMedic (7 substances)
| Substance | Primary indications | Mechanism | Common dose |
|---|---|---|---|
| Ceretec Stabilised | Cerebral perfusion SPECT imaging, Leukocyte labelling for infection/inflammation imaging | Technetium-99m exametazime (HMPAO) — lipophilic chelate that crosses the blood-b | 370-1110 MBq IV depending on indication |
| Exametazim Radiopharmacy Laboratory | Cerebral perfusion imaging, Leukocyte labeling for infection imaging | Technetium-99m labeled lipophilic chelate that crosses the blood-brain barrier a | 370-1110 MBq IV (varies by indication) |
| Macrosalb Medi Radiopharma | Lung perfusion scintigraphy, Pulmonary embolism diagnosis | Technetium-99m labeled albumin macroaggregates lodge in pulmonary capillaries fo | Diagnostic activity 40-150 MBq IV |
| Mibg Curiumpharma | Diagnosis of pheochromocytoma, Neuroblastoma imaging | Iobenguane (123I-MIBG) is a noradrenaline analogue taken up by adrenergic tissue | Single IV dose of 80-200 MBq based on body weight |
| Renocis | Renal imaging and function assessment | Technetium-99m DMSA (dimercaptosuccinic acid) kit accumulating in renal cortex f | Per nuclear medicine protocol |
| Striascan | Differential diagnosis of parkinsonian syndromes, Dementia with Lewy bodies imaging | Ioflupane (123I) binds presynaptic dopamine transporters in striatum for SPECT i | 111-185 MBq intravenously as single dose |
| Tallium Klorid Curiumpharma | Myocardial perfusion imaging, Tumor localization scintigraphy | Thallium-201 chloride is a potassium analog taken up by viable myocardium and ce | 55-111 MBq IV (diagnostic dose) |
About Radiopharmaceutical diagnostic agent
Radiopharmaceutical diagnostic agent share a common mechanism of action and clinical use. Specific dosing, side effects, contraindications, and drug interactions vary between individual substances within the class. Click any substance above for full prescribing information and patient guidance.
Common considerations across the class
- Indication-specific selection: Different members may be preferred for different conditions or patient populations
- Dose equivalence: Members of the same class are not always interchangeable on a 1:1 dose basis
- Drug interactions: Class members often share interaction profiles (e.g., CYP enzyme effects) but individual variation matters
- Side effects: Some side effects are class-wide; others are substance-specific
- Contraindications: Individual contraindications may not generalize across the class
Always consult the prescribing information for the specific medicine prescribed and discuss with your clinician.
Frequently asked questions
What are Radiopharmaceutical diagnostic agent?
Radiopharmaceutical diagnostic agent are medicines that share a common mechanism of action used for specific therapeutic indications. iMedic currently covers 7 substances in this class with detailed pages for each.
Are all Radiopharmaceutical diagnostic agent interchangeable?
No. While medicines in the same class share a mechanism, they differ in potency, dosing, drug interactions, and tolerability. Switching between them is a clinical decision based on individual response, side effects, and treatment goals.
How do I choose between different Radiopharmaceutical diagnostic agent?
Selection depends on the specific clinical indication, patient factors (age, comorbidities, kidney/liver function, other medications), tolerability of side effects, cost, and clinician preference. This is a prescribing decision.
Are Radiopharmaceutical diagnostic agent available as generics?
Most well-established class members are available as generic alternatives, often substantially less expensive than brand-name versions while clinically equivalent. Newer members may still be brand-only.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.